Dr. Tony Reed, the chief medical officer at Temple University Hospital in Philadelphia, has seen remdesivir in action. The hospital system gave the drug to patients in trials to help figure out how well the coronavirus treatment works.on Friday, saying the treatment could help some severely ill patients recover more quickly, Reed and the team at Temple expected that they'd get more access to the medication.
As the government figures out which hospitals will get the drug, severely ill patients who should qualify for treatment aren't getting it, doctors across the country told Business Insider.In some cases, hospitals don't have the drug on hand yet, or aren't able to give it to patients outside the narrow confines of clinical trials. Clinicians said they aren't sure when it will come or how much supply they'll get.
Any delay may be harmful to patients. Antivirals like remdesivir generally work better when given earlier on in the course of an infection. Gilead Sciences, the biotech company that makes remdesivir, has put out some preliminary data suggesting that may be the case with this drug as well.
Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше:
Россия Последние новости, Россия Последние новости
Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей
Will Gilead price its coronavirus drug for public good or company profit?Gilead Sciences Inc faces a new dilemma in deciding how much it should profit from the only treatment so far proven to help patients infected with the novel coronavirus. Enough Oh dear god, this thing trialed worse then some over the counter flu suppliments in china. why is it worth so much ? Pholoho MotheoMothupi TheRealDemoCast 👀
Источник: Reuters - 🏆 2. / 97 Прочитайте больше »
Supply chain expert: Coronavirus a 'learning experience' for companies - Business InsiderThe disrupted supply chains that left store shelves devoid of toilet paper and cleaning supplies could end up being a good lesson for American companies got shop towels instead of regular papertowels at costco yesterday. 1bag =1yr supply, I'm not hoarding. It’s a double edged sword. Multiple suppliers = more expensive and inefficient. How much did the 2 weeks blackout cost in lost sales? Would multiple suppliers have prevented that? Not an easy question, but supplier diversification is costly. Nope we won't learn Makes you wonder how powerful and efficient America really is compared to less affluent countries.This national emergency is revealing a quite lot.
Источник: BusinessInsider - 🏆 729. / 51 Прочитайте больше »
'Call of Duty' publisher Activision funding coronavirus drug research - Business InsiderThe latest 'Call of Duty' has been a sales smash as many people are stuck indoors. Now, its publisher is funding coronavirus-fighting drugs. Jose_Aguilera
Источник: BusinessInsider - 🏆 729. / 51 Прочитайте больше »
Plant-Based Meat Business Booming Amid Beef and Poultry ShortagePlant-based meat business is booming as a meat and poultry shortage looms amid coronavirus pandemic. DEEEEEELICIOUS! i’ll resort to cannibalism before i eat that shit. Plant based meat really doesn't taste that different, & is way better for humans, so, I support that new trend. Just takes a minor adjustment, w/healthy benefits.
Источник: TMZ - 🏆 379. / 59 Прочитайте больше »
Influencers won't be destroyed by the coronavirus advertising meltdown - Business InsiderCreators and marketers are adjusting their businesses amid the coronavirus proving the influencer industry isn't destroyed.
Источник: BusinessInsider - 🏆 729. / 51 Прочитайте больше »